Clinical trial · Observational
Metastatic Tumor Research and Outcomes Network
Metastatic Tumor Research and Outcome Network A Multicenter Prospective Registry for the Management and Outcome of Metastatic Spine Tumors
NCT02830451CI-TRIAL-00104012MTRONactive not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The registry aims to collect patient information such as patient demographics, co-morbidities, clinical, diagnostic, and therapeutic data, as well as information on adverse events and HRQOL outcomes specific for patients with metastatic spine tumor(s).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Metastatic Spine Tumor | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (15)
- measure
- Patient details
- timeFrame
- collected at baseline
- description
- The following patient data will be collected: * gender, year of birth, height, weight, race * work status, education level, marital status * smoking, alcohol and recreational drug use * medication use * nutrition and vitamin intake * presence of osteoporosis * comorbidities according to the Charlson Comorbidity Index - CCI
- measure
- Tumor details
- timeFrame
- collected at baseline, first prospective treatment and follow-up
- description
- Primary cancer * Site of the primary cancer * Year of diagnosis * Status of the tumor (removed completely, partially, or not removed) * Signs of local control or tumor progression * Tumor subtype * Tumor markers Spine metastases * Date of initial diagnosis of spine metastases * Identification of index target * Vertebral location (i.e., C1, T3-T5, etc.) * Details of spine metastases and other metastases, if any * Activity of systemic metastases * Local control of metastatic tumor * Presence of pathologic fracture * Radiographic evidence of new spine metastatic disease
- measure
- Symptoms
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient 18 or older. * Patient diagnosed with a metastatic tumor of the spine * Informed consent obtained, i.e.: * Ability to understand the content of the patient information/ICF * Willingness and ability to participate in the registry according to the Registry Plan * Signed and dated EC/IRB approved written informed consent (if consent is required by the EC/ IRB at the registry site) Exclusion Criteria: • Patient diagnosed with a primary tumor of the spine.
References
Publications (0)
Data not yet available
No reference posted for this study.